AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Cardinal Health Inc. (CAH)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

125.84

-0.37 (-0.29%)

At close: Feb 18, 2025, 3:59 PM

127.26

1.13%

After-hours: Feb 18, 2025, 05:40 PM EST

undefined% (undefined)

Bid	122.8
Market Cap	30.40B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	5.36
PE Ratio (ttm)	23.48
Forward PE	n/a
Analyst	Hold

Ask	127.26
Volume	1,014,427
Avg. Volume (20D)	2,221,271
Open	125.80
Previous Close	126.21
Day's Range	123.94 - 126.13
52-Week Range	93.17 - 132.84
Beta	undefined

About CAH

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and gen...

[Show more]

Industry Medical - Distribution

Sector Healthcare

IPO Date Aug 4, 1983

Employees 47,922

Stock Exchange NYSE

Ticker Symbol CAH

Website https://www.cardinalhealth.com

Full Company Profile

Analyst Forecast

According to 15 analyst ratings, the average rating for CAH stock is "Hold." The 12-month stock price forecast is $137, which is an increase of 8.87% from the latest price.

Buy 60.00%

Hold 33.33%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Cardinal Health Inc. is scheduled to release its earnings on May 1, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

+7.01%

Cardinal Health shares are trading higher after th... Unlock content with Pro Subscription

6 months ago

+3.68%

Cardinal Health shares are trading higher after the company reported strong Q4 results and raised its 2025 outlook.

News

22 hours ago · zacks.com

5 Broker-Loved Stocks to Keep an Eye on After Recent Analyst Upgrades

Investors should monitor stocks like Dana, Camping World, ABM, Cardinal Health and DXC for high returns.

1 week ago · zacks.com

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 weeks ago · benzinga.com

Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings

Cardinal Health CAH reported better-than-expected second-quarter financial results on Thursday.

2 weeks ago · seekingalpha.com

Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript

Cardinal Health, Inc. (NYSE:CAH ) Q2 2025 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Office...

2 weeks ago · zacks.com

CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised

Cardinal Health's second-quarter fiscal 2025 results benefit from solid Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.

2 weeks ago · zacks.com

Here's Why Cardinal Health (CAH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

2 weeks ago · zacks.com

Cardinal (CAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stre...

2 weeks ago · zacks.com

Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe...

2 weeks ago · zacks.com

Cardinal Health (CAH) Surpasses Q2 Earnings and Revenue Estimates

Cardinal Health (CAH) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.82 per share a year ago.

2 weeks ago · reuters.com

Cardinal Health lifts 2025 profit forecast on specialty drugs demand

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Load More News